TIDMERGO
Ergomed plc
18 May 2020
RNS REACH
PRESS RELEASE
Ergomed Enters Strategic Collaboration to Drive
Pharmacovigilance Leadership in Intelligent Automation
PrimeVigilance collaboration with Automation Anywhere and
DataRobot to advance
robotic processes and machine learning
Guildford, UK - 18 May 2020: Ergomed plc (LSE: ERGO) ('Ergomed'
or the 'Company'), a company focused on providing specialised
services to the pharmaceutical industry, is pleased to announce
PrimeVigilance's strategic collaboration with Automation Anywhere,
a global leader in Robotic Process Automation (RPA) and DataRobot,
the leader in enterprise artificial intelligence (AI), to
accelerate the Company's Intelligent Automation strategy.
PrimeVigilance, a division of Ergomed, is the leading global
specialized provider of full pharmacovigilance (PV) services, and
currently employs over 750 people. By empowering its clients and
colleagues with the application of RPA and Machine Learning (ML),
PrimeVigilance will enable clients to improve quality and
consistency within safety databases, as well as productivity.
A successful proof of concept has been completed, and
PrimeVigilance will now implement a cloud software solution to
automate specific pharmacovigilance processes. The productivity
gains made possible by working with Automation Anywhere and
DataRobot, are expected to deliver organic growth more efficiently,
with the automation of manual, repetitive processes. Automation
Anywhere's cloud-based RPA on its digital workforce platform
combined with DataRobot's enterprise AI platform will bring new
levels of speed and intelligence to a crucial component of the
business, freeing up valuable hours for highly trained
pharmacovigilance professionals to focus on value creation and
problem solving that only humans can address.
This strategic partnership will be part of Ergomed's wider
strategy as it transforms the relationship between its people and
technology, enhancing the Company's creativity, agility and skills
for the benefit of its clients and shareholders. It will enhance
Ergomed's existing skills and expertise by combining human insight
and knowledge with the intelligent application of technology to
enhance the speed and precision of analysis and decision
making.
Dr Miroslav Reljanović , Executive Chairman of Ergomed, said: "
Adoption of t he latest available technologies, including
automation and robotic technology across our pharmacovigilance
business , ensures we are able to continue to offer cutting edge
services to our customers. This collaboration provides the
foundation to rapidly identify and automate a wide range of
business processes, enabling clients to maximise quality and
consistency within safety databases as well as increasing
productivity."
Prince Kohli, Chief Technology Officer at Automation Anywhere,
commented: "Intelligent Automation can help to unlock valuable
human capacity to focus on innovation-led projects, while reducing
costs and shortening the time to market. Ergomed understands this
opportunity, and we're excited to be working with them and
DataRobot to unleash the potential of Intelligent Automation to
enable a better customer experience and faster time to value."
Automation Anywhere Enterprise A2019, was designed from the
ground up as a cloud-native and web-based RPA platform offering
lower total cost of ownership (TCO), increased performance and
scalability. It combines advanced RPA, artificial intelligence (AI)
and embedded analytics, enabling enterprises to digitize business
operations, driving scalability, reusability and lowering operating
costs. The company's software bots, which are delivered via the
cloud, work side-by-side with human workers to automate repetitive,
mundane tasks, freeing up valuable human resources to focus on more
meaningful work.
"Companies across all sectors and geographies have learned that
they can transform their business by embracing Intelligent
Automation," said Dan Wright, President and COO, DataRobot. "By
implementing this technology, companies can combine the best of
human and machine intelligence, drive rapid automation and enhanced
operational efficiency, and experience exponential returns on their
investment. We're excited to have teamed up with Automation
Anywhere to help Ergomed push the boundaries of what's
possible."
DataRobot is the leader in enterprise AI, delivering trusted AI
technology and return on investment (ROI) enablement services to
global enterprises competing in today's Intelligence Revolution.
DataRobot's enterprise AI platform democratizes data science with
end-to-end automation for building, deploying, and managing machine
learning models.
ENDS
Enquiries:
Ergomed plc Tel: +44 (0) 1483 402
975
Miroslav Reljanović (Executive Chairman)
Richard Barfield (Chief Financial Officer)
Numis Securities Limited Tel: +44 (0) 20 7260 1000
Freddie Barnfield / Huw Jeremy (Nominated
Adviser)
James Black (Broker)
Consilium Strategic Communications - for Tel: +44 (0) 20 3709 5700
UK enquiries
Chris Gardner / Sue Stuart ergomed@consilium-comms.com
Matthew Neal / Olivia Manser
Automation Anywhere Tel: +44 79 32552473
Kerry Davis Kerry.davis@automationanywhere.com
DataRobot Tel: +1-617-765-4500
Libby Botsford Elizabeth.botsford@datarobot.com
About Ergomed plc
Ergomed provides specialist services to the pharmaceutical
industry spanning all phases of clinical development, post-approval
pharmacovigilance and medical information. Ergomed's fast-growing,
profitable services business includes an industry leading suite of
specialist pharmacovigilance solutions, integrated under the
PrimeVigilance brand, a full range of high-quality contract
research and trial management services under the Ergomed brand
(CRO), and an internationally recognised specialist expertise in
orphan drug development, under PSR. For further information, visit:
http://ergomedplc.com .
About Automation Anywhere
Automation Anywhere is a global leader in Robotic Process
Automation (RPA), empowering customers to automate end-to-end
business processes with software bots - digital workers that
perform repetitive and manual tasks, resulting in dramatic
productivity gains, optimized customer experience and more engaged
employees. The company offers the world's only web-based and
cloud-native intelligent automation platform combining RPA,
artificial intelligence, machine learning, and analytics right out
of the box, to help organizations rapidly start and scale their
process automation journey. Its Bot Store is the world's first and
largest marketplace with more than 850 pre-built, intelligent
automation solutions. With offices in more than 40 countries and a
global network of 1,500 partners, Automation Anywhere has deployed
over 1.8 million bots to support some of the world's largest
enterprises across all industries. For additional information,
visit www.automationanywhere.com .
About DataRobot
DataRobot is the leader in enterprise AI, delivering trusted AI
technology and enablement services to global enterprises competing
in today's Intelligence Revolution. DataRobot's enterprise AI
platform democratizes data science with end-to-end automation for
building, deploying, and managing machine learning models. This
platform maximizes business value by delivering AI at scale and
continuously optimizing performance over time. The company's proven
combination of cutting-edge software and world-class AI
implementation, training, and support services, empowers any
organization - regardless of size, industry, or resources - to
drive better business outcomes with AI.
With a singular focus on AI since its inception, DataRobot has a
proven track record of delivering AI with ROI. DataRobot has
offices across the globe and $431 million in funding from top-tier
firms, including New Enterprise Associates, Sapphire Ventures,
Meritech, and DFJ Growth. For more information, visit
https://www.datarobot.com , and join the conversation on Twitter
and LinkedIn .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAGPUQWAUPUPUM
(END) Dow Jones Newswires
May 18, 2020 02:00 ET (06:00 GMT)
Ergomed (LSE:ERGO)
Historical Stock Chart
From Apr 2024 to May 2024
Ergomed (LSE:ERGO)
Historical Stock Chart
From May 2023 to May 2024